In immuno-oncology, the co-occurrence of therapy concepts and cancer types provides valuable insights into the interconnectedness of various therapeutic strategies and their applications across different malignancies. Analyzing these co-occurrences helps identify effective therapeutic strategies, research trends, and potential areas for future investigation This understanding is crucial for developing more effective and personalized cancer immunotherapies, ultimately improving patient outcomes. • Immune checkpoint antibodies | Liver cancer Traditionally, liver cancer has been challenging to treat, with limited options for advanced stages.